nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—uterine cancer—sarcoma	0.559	1	CtDrD
Progesterone—CYP1B1—Mitoxantrone—sarcoma	0.0332	0.102	CbGbCtD
Progesterone—ABCC1—Dactinomycin—sarcoma	0.0263	0.081	CbGbCtD
Progesterone—SLC22A3—Vincristine—sarcoma	0.0248	0.0764	CbGbCtD
Progesterone—ABCC1—Mitoxantrone—sarcoma	0.0236	0.0725	CbGbCtD
Progesterone—ABCB11—Vincristine—sarcoma	0.0228	0.0702	CbGbCtD
Progesterone—ABCC1—Epirubicin—sarcoma	0.0191	0.0586	CbGbCtD
Progesterone—CYP1A1—Dacarbazine—sarcoma	0.0188	0.0577	CbGbCtD
Progesterone—ABCC1—Vincristine—sarcoma	0.0162	0.0499	CbGbCtD
Progesterone—ABCC1—Etoposide—sarcoma	0.0149	0.0457	CbGbCtD
Progesterone—ABCB11—Doxorubicin—sarcoma	0.0143	0.0439	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—sarcoma	0.0143	0.0439	CbGbCtD
Progesterone—ABCC1—Doxorubicin—sarcoma	0.0101	0.0312	CbGbCtD
Progesterone—CYP1A2—Dacarbazine—sarcoma	0.00838	0.0258	CbGbCtD
Progesterone—CYP3A7—Vincristine—sarcoma	0.00802	0.0246	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.00802	0.0246	CbGbCtD
Progesterone—CYP3A4—Thiotepa—sarcoma	0.00793	0.0244	CbGbCtD
Progesterone—ABCB1—Dactinomycin—sarcoma	0.00636	0.0195	CbGbCtD
Progesterone—CYP3A5—Vincristine—sarcoma	0.00602	0.0185	CbGbCtD
Progesterone—ABCB1—Mitoxantrone—sarcoma	0.00569	0.0175	CbGbCtD
Progesterone—CYP3A5—Etoposide—sarcoma	0.00551	0.0169	CbGbCtD
Progesterone—CYP2C8—Etoposide—sarcoma	0.0053	0.0163	CbGbCtD
Progesterone—CYP1A2—Etoposide—sarcoma	0.0041	0.0126	CbGbCtD
Progesterone—ABCB1—Vincristine—sarcoma	0.00391	0.012	CbGbCtD
Progesterone—ABCB1—Etoposide—sarcoma	0.00359	0.011	CbGbCtD
Progesterone—CYP3A4—Mitoxantrone—sarcoma	0.00341	0.0105	CbGbCtD
Progesterone—AR—scrotum—sarcoma	0.00251	0.079	CbGeAlD
Progesterone—ABCB1—Doxorubicin—sarcoma	0.00245	0.00752	CbGbCtD
Progesterone—CYP3A4—Vincristine—sarcoma	0.00235	0.00721	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—sarcoma	0.00231	0.00709	CbGbCtD
Progesterone—CYP3A4—Etoposide—sarcoma	0.00215	0.00661	CbGbCtD
Progesterone—CYP3A4—Doxorubicin—sarcoma	0.00147	0.00451	CbGbCtD
Progesterone—SHBG—hindlimb—sarcoma	0.00119	0.0375	CbGeAlD
Progesterone—ESR1—periosteum—sarcoma	0.00118	0.0371	CbGeAlD
Progesterone—SLC10A1—seminal vesicle—sarcoma	0.000491	0.0154	CbGeAlD
Progesterone—PGR—mammary gland—sarcoma	0.000448	0.0141	CbGeAlD
Progesterone—SIGMAR1—mammary gland—sarcoma	0.000396	0.0125	CbGeAlD
Progesterone—CYP17A1—connective tissue—sarcoma	0.000391	0.0123	CbGeAlD
Progesterone—CYP1B1—mammary gland—sarcoma	0.000377	0.0119	CbGeAlD
Progesterone—ESR1—mammary gland—sarcoma	0.00035	0.011	CbGeAlD
Progesterone—NR3C2—myometrium—sarcoma	0.000342	0.0108	CbGeAlD
Progesterone—CYP2A6—seminal vesicle—sarcoma	0.00033	0.0104	CbGeAlD
Progesterone—PGR—myometrium—sarcoma	0.000318	0.01	CbGeAlD
Progesterone—NR3C2—seminal vesicle—sarcoma	0.000309	0.00972	CbGeAlD
Progesterone—SHBG—hematopoietic system—sarcoma	0.000303	0.00954	CbGeAlD
Progesterone—NR3C2—hematopoietic system—sarcoma	0.000294	0.00924	CbGeAlD
Progesterone—SHBG—connective tissue—sarcoma	0.000292	0.00918	CbGeAlD
Progesterone—SLC22A3—myometrium—sarcoma	0.000291	0.00916	CbGeAlD
Progesterone—CYP2C8—mammary gland—sarcoma	0.000289	0.00908	CbGeAlD
Progesterone—NR3C2—connective tissue—sarcoma	0.000283	0.0089	CbGeAlD
Progesterone—SIGMAR1—myometrium—sarcoma	0.000281	0.00885	CbGeAlD
Progesterone—SLC22A3—embryo—sarcoma	0.00028	0.00881	CbGeAlD
Progesterone—PGR—hematopoietic system—sarcoma	0.000273	0.00859	CbGeAlD
Progesterone—SLC22A3—seminal vesicle—sarcoma	0.000263	0.00827	CbGeAlD
Progesterone—PGR—connective tissue—sarcoma	0.000263	0.00827	CbGeAlD
Progesterone—NR3C2—smooth muscle tissue—sarcoma	0.000259	0.00814	CbGeAlD
Progesterone—CYP2C9—mammary gland—sarcoma	0.000256	0.00807	CbGeAlD
Progesterone—SLC10A1—testis—sarcoma	0.000256	0.00805	CbGeAlD
Progesterone—SIGMAR1—seminal vesicle—sarcoma	0.000254	0.008	CbGeAlD
Progesterone—AR—myometrium—sarcoma	0.000253	0.00797	CbGeAlD
Progesterone—ABCB11—testis—sarcoma	0.000253	0.00795	CbGeAlD
Progesterone—SLC22A3—hematopoietic system—sarcoma	0.00025	0.00786	CbGeAlD
Progesterone—ESR1—myometrium—sarcoma	0.000249	0.00782	CbGeAlD
Progesterone—SLC10A1—liver—sarcoma	0.000242	0.00761	CbGeAlD
Progesterone—ABCC1—myometrium—sarcoma	0.00024	0.00757	CbGeAlD
Progesterone—SLC22A3—connective tissue—sarcoma	0.00024	0.00757	CbGeAlD
Progesterone—PGR—smooth muscle tissue—sarcoma	0.00024	0.00757	CbGeAlD
Progesterone—ESR1—embryo—sarcoma	0.000239	0.00753	CbGeAlD
Progesterone—ABCB11—liver—sarcoma	0.000239	0.00752	CbGeAlD
Progesterone—CYP3A7—liver—sarcoma	0.000234	0.00735	CbGeAlD
Progesterone—CYP1B1—hematopoietic system—sarcoma	0.00023	0.00723	CbGeAlD
Progesterone—SHBG—uterus—sarcoma	0.000229	0.0072	CbGeAlD
Progesterone—AR—seminal vesicle—sarcoma	0.000229	0.0072	CbGeAlD
Progesterone—NR3C2—cardiac atrium—sarcoma	0.000223	0.00702	CbGeAlD
Progesterone—CYP17A1—testis—sarcoma	0.000223	0.00701	CbGeAlD
Progesterone—NR3C2—uterus—sarcoma	0.000222	0.00698	CbGeAlD
Progesterone—CYP1B1—connective tissue—sarcoma	0.000221	0.00696	CbGeAlD
Progesterone—SLC22A3—smooth muscle tissue—sarcoma	0.00022	0.00692	CbGeAlD
Progesterone—AR—hematopoietic system—sarcoma	0.000217	0.00684	CbGeAlD
Progesterone—ABCC1—seminal vesicle—sarcoma	0.000217	0.00684	CbGeAlD
Progesterone—ESR1—hematopoietic system—sarcoma	0.000213	0.00672	CbGeAlD
Progesterone—SIGMAR1—smooth muscle tissue—sarcoma	0.000213	0.00669	CbGeAlD
Progesterone—CYP17A1—liver—sarcoma	0.000211	0.00663	CbGeAlD
Progesterone—AR—connective tissue—sarcoma	0.000209	0.00659	CbGeAlD
Progesterone—PGR—uterus—sarcoma	0.000206	0.00649	CbGeAlD
Progesterone—ESR1—connective tissue—sarcoma	0.000206	0.00647	CbGeAlD
Progesterone—CYP1B1—smooth muscle tissue—sarcoma	0.000202	0.00636	CbGeAlD
Progesterone—CYP2C19—hematopoietic system—sarcoma	0.000201	0.00634	CbGeAlD
Progesterone—CYP1B1—skin of body—sarcoma	0.0002	0.00628	CbGeAlD
Progesterone—CYP3A7-CYP3A51P—liver—sarcoma	0.000199	0.00625	CbGeAlD
Progesterone—NR3C2—tendon—sarcoma	0.000194	0.00612	CbGeAlD
Progesterone—SHBG—bone marrow—sarcoma	0.000194	0.00611	CbGeAlD
Progesterone—PGR—lymphoid tissue—sarcoma	0.000192	0.00605	CbGeAlD
Progesterone—AR—smooth muscle tissue—sarcoma	0.000191	0.00603	CbGeAlD
Progesterone—AR—skin of body—sarcoma	0.000189	0.00595	CbGeAlD
Progesterone—ESR1—smooth muscle tissue—sarcoma	0.000188	0.00592	CbGeAlD
Progesterone—NR3C1—myometrium—sarcoma	0.000183	0.00577	CbGeAlD
Progesterone—SIGMAR1—cardiac atrium—sarcoma	0.000183	0.00577	CbGeAlD
Progesterone—SIGMAR1—uterus—sarcoma	0.000182	0.00574	CbGeAlD
Progesterone—NR3C1—embryo—sarcoma	0.000176	0.00555	CbGeAlD
Progesterone—CYP2C8—hematopoietic system—sarcoma	0.000176	0.00553	CbGeAlD
Progesterone—CYP1B1—uterus—sarcoma	0.000173	0.00546	CbGeAlD
Progesterone—SHBG—testis—sarcoma	0.000166	0.00523	CbGeAlD
Progesterone—NR3C1—seminal vesicle—sarcoma	0.000166	0.00522	CbGeAlD
Progesterone—AR—cardiac atrium—sarcoma	0.000165	0.0052	CbGeAlD
Progesterone—CYP1A2—hematopoietic system—sarcoma	0.000165	0.00518	CbGeAlD
Progesterone—AR—uterus—sarcoma	0.000164	0.00517	CbGeAlD
Progesterone—CYP1A1—hematopoietic system—sarcoma	0.000162	0.00511	CbGeAlD
Progesterone—CYP2A6—liver—sarcoma	0.000162	0.00511	CbGeAlD
Progesterone—CYP1B1—lymphoid tissue—sarcoma	0.000162	0.00509	CbGeAlD
Progesterone—CYP17A1—lymph node—sarcoma	0.000161	0.00508	CbGeAlD
Progesterone—ESR1—uterus—sarcoma	0.000161	0.00507	CbGeAlD
Progesterone—NR3C2—testis—sarcoma	0.000161	0.00506	CbGeAlD
Progesterone—SIGMAR1—tendon—sarcoma	0.00016	0.00503	CbGeAlD
Progesterone—CYP3A5—hematopoietic system—sarcoma	0.000159	0.00499	CbGeAlD
Progesterone—NR3C1—hematopoietic system—sarcoma	0.000157	0.00496	CbGeAlD
Progesterone—SHBG—liver—sarcoma	0.000157	0.00494	CbGeAlD
Progesterone—ABCC1—cardiac atrium—sarcoma	0.000157	0.00494	CbGeAlD
Progesterone—CYP2C9—hematopoietic system—sarcoma	0.000156	0.00492	CbGeAlD
Progesterone—ABCC1—uterus—sarcoma	0.000156	0.00491	CbGeAlD
Progesterone—SIGMAR1—bone marrow—sarcoma	0.000155	0.00487	CbGeAlD
Progesterone—AR—lymphoid tissue—sarcoma	0.000153	0.00482	CbGeAlD
Progesterone—NR3C2—liver—sarcoma	0.000152	0.00479	CbGeAlD
Progesterone—CYP1B1—tendon—sarcoma	0.000152	0.00478	CbGeAlD
Progesterone—NR3C1—connective tissue—sarcoma	0.000152	0.00477	CbGeAlD
Progesterone—ESR1—lymphoid tissue—sarcoma	0.00015	0.00473	CbGeAlD
Progesterone—PGR—testis—sarcoma	0.00015	0.00471	CbGeAlD
Progesterone—AR—tendon—sarcoma	0.000144	0.00453	CbGeAlD
Progesterone—CYP1A1—skin of body—sarcoma	0.000141	0.00444	CbGeAlD
Progesterone—NR3C1—smooth muscle tissue—sarcoma	0.000139	0.00437	CbGeAlD
Progesterone—NR3C1—skin of body—sarcoma	0.000137	0.00431	CbGeAlD
Progesterone—SLC22A3—testis—sarcoma	0.000137	0.00431	CbGeAlD
Progesterone—ABCC1—tendon—sarcoma	0.000137	0.0043	CbGeAlD
Progesterone—SLC22A1—liver—sarcoma	0.000135	0.00426	CbGeAlD
Progesterone—SIGMAR1—testis—sarcoma	0.000132	0.00416	CbGeAlD
Progesterone—SLC22A3—liver—sarcoma	0.000129	0.00407	CbGeAlD
Progesterone—CYP1B1—testis—sarcoma	0.000126	0.00396	CbGeAlD
Progesterone—SIGMAR1—liver—sarcoma	0.000125	0.00394	CbGeAlD
Progesterone—CYP1A1—cardiac atrium—sarcoma	0.000123	0.00388	CbGeAlD
Progesterone—CYP1A1—uterus—sarcoma	0.000123	0.00386	CbGeAlD
Progesterone—NR3C1—cardiac atrium—sarcoma	0.00012	0.00376	CbGeAlD
Progesterone—AR—testis—sarcoma	0.000119	0.00375	CbGeAlD
Progesterone—CYP3A4—hematopoietic system—sarcoma	0.000119	0.00375	CbGeAlD
Progesterone—CYP1B1—liver—sarcoma	0.000119	0.00374	CbGeAlD
Progesterone—NR3C1—uterus—sarcoma	0.000119	0.00374	CbGeAlD
Progesterone—CYP2D6—hematopoietic system—sarcoma	0.000117	0.00369	CbGeAlD
Progesterone—ESR1—testis—sarcoma	0.000117	0.00368	CbGeAlD
Progesterone—NR3C2—lymph node—sarcoma	0.000117	0.00367	CbGeAlD
Progesterone—ABCC1—testis—sarcoma	0.000113	0.00356	CbGeAlD
Progesterone—AR—liver—sarcoma	0.000113	0.00355	CbGeAlD
Progesterone—NR3C1—lymphoid tissue—sarcoma	0.000111	0.00349	CbGeAlD
Progesterone—ESR1—liver—sarcoma	0.000111	0.00348	CbGeAlD
Progesterone—PGR—lymph node—sarcoma	0.000108	0.00341	CbGeAlD
Progesterone—ABCC1—liver—sarcoma	0.000107	0.00337	CbGeAlD
Progesterone—CYP2C19—liver—sarcoma	0.000104	0.00329	CbGeAlD
Progesterone—NR3C1—tendon—sarcoma	0.000104	0.00328	CbGeAlD
Progesterone—NR3C1—bone marrow—sarcoma	0.000101	0.00318	CbGeAlD
Progesterone—SLC22A3—lymph node—sarcoma	9.92e-05	0.00312	CbGeAlD
Progesterone—ABCB1—myometrium—sarcoma	9.82e-05	0.00309	CbGeAlD
Progesterone—CYP2C8—testis—sarcoma	9.64e-05	0.00303	CbGeAlD
Progesterone—SIGMAR1—lymph node—sarcoma	9.59e-05	0.00302	CbGeAlD
Progesterone—ABCB1—embryo—sarcoma	9.44e-05	0.00297	CbGeAlD
Progesterone—CYP1B1—lymph node—sarcoma	9.12e-05	0.00287	CbGeAlD
Progesterone—CYP2C8—liver—sarcoma	9.11e-05	0.00287	CbGeAlD
Progesterone—ABCB1—seminal vesicle—sarcoma	8.87e-05	0.00279	CbGeAlD
Progesterone—AR—lymph node—sarcoma	8.64e-05	0.00272	CbGeAlD
Progesterone—NR3C1—testis—sarcoma	8.63e-05	0.00272	CbGeAlD
Progesterone—CYP1A2—liver—sarcoma	8.52e-05	0.00268	CbGeAlD
Progesterone—ESR1—lymph node—sarcoma	8.48e-05	0.00267	CbGeAlD
Progesterone—ABCB1—hematopoietic system—sarcoma	8.43e-05	0.00265	CbGeAlD
Progesterone—CYP1A1—liver—sarcoma	8.41e-05	0.00265	CbGeAlD
Progesterone—CYP3A5—liver—sarcoma	8.22e-05	0.00259	CbGeAlD
Progesterone—ABCC1—lymph node—sarcoma	8.2e-05	0.00258	CbGeAlD
Progesterone—NR3C1—liver—sarcoma	8.16e-05	0.00257	CbGeAlD
Progesterone—CYP2C9—liver—sarcoma	8.09e-05	0.00255	CbGeAlD
Progesterone—Gastritis—Doxorubicin—sarcoma	6.5e-05	0.000962	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Doxorubicin—sarcoma	6.47e-05	0.000958	CcSEcCtD
Progesterone—CYP1A1—lymph node—sarcoma	6.45e-05	0.00203	CbGeAlD
Progesterone—CYP2D6—testis—sarcoma	6.42e-05	0.00202	CbGeAlD
Progesterone—Dysuria—Epirubicin—sarcoma	6.41e-05	0.000949	CcSEcCtD
Progesterone—Dizziness—Thiotepa—sarcoma	6.4e-05	0.000948	CcSEcCtD
Progesterone—Abdominal distension—Doxorubicin—sarcoma	6.39e-05	0.000946	CcSEcCtD
Progesterone—Upper respiratory tract infection—Epirubicin—sarcoma	6.37e-05	0.000943	CcSEcCtD
Progesterone—ABCB1—uterus—sarcoma	6.37e-05	0.002	CbGeAlD
Progesterone—Dysphagia—Doxorubicin—sarcoma	6.34e-05	0.000939	CcSEcCtD
Progesterone—Asthma—Doxorubicin—sarcoma	6.34e-05	0.000939	CcSEcCtD
Progesterone—Pollakiuria—Epirubicin—sarcoma	6.33e-05	0.000938	CcSEcCtD
Progesterone—Hypersensitivity—Vincristine—sarcoma	6.33e-05	0.000937	CcSEcCtD
Progesterone—NR3C1—lymph node—sarcoma	6.26e-05	0.00197	CbGeAlD
Progesterone—Paraesthesia—Etoposide—sarcoma	6.25e-05	0.000925	CcSEcCtD
Progesterone—Weight increased—Epirubicin—sarcoma	6.24e-05	0.000924	CcSEcCtD
Progesterone—Weight decreased—Epirubicin—sarcoma	6.2e-05	0.000918	CcSEcCtD
Progesterone—Dyspnoea—Etoposide—sarcoma	6.2e-05	0.000918	CcSEcCtD
Progesterone—Hyperglycaemia—Epirubicin—sarcoma	6.19e-05	0.000916	CcSEcCtD
Progesterone—Somnolence—Etoposide—sarcoma	6.18e-05	0.000915	CcSEcCtD
Progesterone—Angina pectoris—Doxorubicin—sarcoma	6.18e-05	0.000915	CcSEcCtD
Progesterone—CYP3A4—liver—sarcoma	6.17e-05	0.00194	CbGeAlD
Progesterone—Hypersensitivity—Mitoxantrone—sarcoma	6.16e-05	0.000912	CcSEcCtD
Progesterone—Asthenia—Vincristine—sarcoma	6.16e-05	0.000912	CcSEcCtD
Progesterone—Vomiting—Thiotepa—sarcoma	6.16e-05	0.000911	CcSEcCtD
Progesterone—Pneumonia—Epirubicin—sarcoma	6.15e-05	0.00091	CcSEcCtD
Progesterone—Infestation—Epirubicin—sarcoma	6.11e-05	0.000905	CcSEcCtD
Progesterone—Infestation NOS—Epirubicin—sarcoma	6.11e-05	0.000905	CcSEcCtD
Progesterone—Drowsiness—Epirubicin—sarcoma	6.11e-05	0.000905	CcSEcCtD
Progesterone—Vomiting—Dactinomycin—sarcoma	6.11e-05	0.000905	CcSEcCtD
Progesterone—Rash—Thiotepa—sarcoma	6.11e-05	0.000904	CcSEcCtD
Progesterone—Bronchitis—Doxorubicin—sarcoma	6.1e-05	0.000903	CcSEcCtD
Progesterone—Dermatitis—Thiotepa—sarcoma	6.1e-05	0.000903	CcSEcCtD
Progesterone—CYP2D6—liver—sarcoma	6.07e-05	0.00191	CbGeAlD
Progesterone—Headache—Thiotepa—sarcoma	6.07e-05	0.000898	CcSEcCtD
Progesterone—Rash—Dactinomycin—sarcoma	6.06e-05	0.000897	CcSEcCtD
Progesterone—Decreased appetite—Etoposide—sarcoma	6.05e-05	0.000895	CcSEcCtD
Progesterone—Gastrointestinal disorder—Etoposide—sarcoma	6.01e-05	0.000889	CcSEcCtD
Progesterone—Asthenia—Mitoxantrone—sarcoma	6e-05	0.000888	CcSEcCtD
Progesterone—Fatigue—Etoposide—sarcoma	6e-05	0.000888	CcSEcCtD
Progesterone—Neuropathy peripheral—Epirubicin—sarcoma	5.99e-05	0.000887	CcSEcCtD
Progesterone—Jaundice—Epirubicin—sarcoma	5.96e-05	0.000882	CcSEcCtD
Progesterone—Pain—Etoposide—sarcoma	5.95e-05	0.000881	CcSEcCtD
Progesterone—Constipation—Etoposide—sarcoma	5.95e-05	0.000881	CcSEcCtD
Progesterone—Urinary tract infection—Epirubicin—sarcoma	5.94e-05	0.00088	CcSEcCtD
Progesterone—Conjunctivitis—Epirubicin—sarcoma	5.94e-05	0.00088	CcSEcCtD
Progesterone—ABCB1—lymphoid tissue—sarcoma	5.93e-05	0.00187	CbGeAlD
Progesterone—Dysuria—Doxorubicin—sarcoma	5.93e-05	0.000878	CcSEcCtD
Progesterone—Upper respiratory tract infection—Doxorubicin—sarcoma	5.9e-05	0.000873	CcSEcCtD
Progesterone—Diarrhoea—Vincristine—sarcoma	5.88e-05	0.00087	CcSEcCtD
Progesterone—Pollakiuria—Doxorubicin—sarcoma	5.86e-05	0.000868	CcSEcCtD
Progesterone—Hepatobiliary disease—Epirubicin—sarcoma	5.78e-05	0.000856	CcSEcCtD
Progesterone—Weight increased—Doxorubicin—sarcoma	5.77e-05	0.000855	CcSEcCtD
Progesterone—Nausea—Thiotepa—sarcoma	5.75e-05	0.000852	CcSEcCtD
Progesterone—Weight decreased—Doxorubicin—sarcoma	5.74e-05	0.00085	CcSEcCtD
Progesterone—Sinusitis—Epirubicin—sarcoma	5.74e-05	0.000849	CcSEcCtD
Progesterone—Feeling abnormal—Etoposide—sarcoma	5.73e-05	0.000849	CcSEcCtD
Progesterone—Hyperglycaemia—Doxorubicin—sarcoma	5.72e-05	0.000847	CcSEcCtD
Progesterone—Diarrhoea—Mitoxantrone—sarcoma	5.72e-05	0.000847	CcSEcCtD
Progesterone—Nausea—Dactinomycin—sarcoma	5.71e-05	0.000845	CcSEcCtD
Progesterone—Pneumonia—Doxorubicin—sarcoma	5.69e-05	0.000842	CcSEcCtD
Progesterone—Gastrointestinal pain—Etoposide—sarcoma	5.69e-05	0.000842	CcSEcCtD
Progesterone—Dizziness—Vincristine—sarcoma	5.68e-05	0.000841	CcSEcCtD
Progesterone—Infestation—Doxorubicin—sarcoma	5.66e-05	0.000837	CcSEcCtD
Progesterone—Infestation NOS—Doxorubicin—sarcoma	5.66e-05	0.000837	CcSEcCtD
Progesterone—Drowsiness—Doxorubicin—sarcoma	5.66e-05	0.000837	CcSEcCtD
Progesterone—Neuropathy peripheral—Doxorubicin—sarcoma	5.55e-05	0.000821	CcSEcCtD
Progesterone—Urticaria—Etoposide—sarcoma	5.53e-05	0.000818	CcSEcCtD
Progesterone—Haemoglobin—Epirubicin—sarcoma	5.52e-05	0.000817	CcSEcCtD
Progesterone—Jaundice—Doxorubicin—sarcoma	5.51e-05	0.000816	CcSEcCtD
Progesterone—Rhinitis—Epirubicin—sarcoma	5.5e-05	0.000815	CcSEcCtD
Progesterone—Body temperature increased—Etoposide—sarcoma	5.5e-05	0.000814	CcSEcCtD
Progesterone—Abdominal pain—Etoposide—sarcoma	5.5e-05	0.000814	CcSEcCtD
Progesterone—Urinary tract infection—Doxorubicin—sarcoma	5.5e-05	0.000814	CcSEcCtD
Progesterone—Conjunctivitis—Doxorubicin—sarcoma	5.5e-05	0.000814	CcSEcCtD
Progesterone—Haemorrhage—Epirubicin—sarcoma	5.49e-05	0.000812	CcSEcCtD
Progesterone—Hepatitis—Epirubicin—sarcoma	5.49e-05	0.000812	CcSEcCtD
Progesterone—Vomiting—Vincristine—sarcoma	5.46e-05	0.000808	CcSEcCtD
Progesterone—Pharyngitis—Epirubicin—sarcoma	5.45e-05	0.000806	CcSEcCtD
Progesterone—Urinary tract disorder—Epirubicin—sarcoma	5.42e-05	0.000802	CcSEcCtD
Progesterone—Rash—Vincristine—sarcoma	5.41e-05	0.000802	CcSEcCtD
Progesterone—Dermatitis—Vincristine—sarcoma	5.41e-05	0.000801	CcSEcCtD
Progesterone—Oedema peripheral—Epirubicin—sarcoma	5.41e-05	0.0008	CcSEcCtD
Progesterone—ABCB1—bone marrow—sarcoma	5.4e-05	0.0017	CbGeAlD
Progesterone—Connective tissue disorder—Epirubicin—sarcoma	5.39e-05	0.000798	CcSEcCtD
Progesterone—Urethral disorder—Epirubicin—sarcoma	5.38e-05	0.000796	CcSEcCtD
Progesterone—Headache—Vincristine—sarcoma	5.38e-05	0.000796	CcSEcCtD
Progesterone—Hepatobiliary disease—Doxorubicin—sarcoma	5.35e-05	0.000792	CcSEcCtD
Progesterone—Vomiting—Mitoxantrone—sarcoma	5.32e-05	0.000787	CcSEcCtD
Progesterone—Sinusitis—Doxorubicin—sarcoma	5.31e-05	0.000786	CcSEcCtD
Progesterone—Visual impairment—Epirubicin—sarcoma	5.29e-05	0.000783	CcSEcCtD
Progesterone—Rash—Mitoxantrone—sarcoma	5.27e-05	0.000781	CcSEcCtD
Progesterone—Dermatitis—Mitoxantrone—sarcoma	5.27e-05	0.00078	CcSEcCtD
Progesterone—Headache—Mitoxantrone—sarcoma	5.24e-05	0.000776	CcSEcCtD
Progesterone—Erythema multiforme—Epirubicin—sarcoma	5.19e-05	0.000768	CcSEcCtD
Progesterone—Eye disorder—Epirubicin—sarcoma	5.13e-05	0.000759	CcSEcCtD
Progesterone—Hypersensitivity—Etoposide—sarcoma	5.13e-05	0.000759	CcSEcCtD
Progesterone—Tinnitus—Epirubicin—sarcoma	5.12e-05	0.000758	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—sarcoma	5.1e-05	0.000756	CcSEcCtD
Progesterone—Nausea—Vincristine—sarcoma	5.1e-05	0.000755	CcSEcCtD
Progesterone—Cardiac disorder—Epirubicin—sarcoma	5.09e-05	0.000754	CcSEcCtD
Progesterone—Rhinitis—Doxorubicin—sarcoma	5.09e-05	0.000754	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—sarcoma	5.08e-05	0.000752	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—sarcoma	5.08e-05	0.000752	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—sarcoma	5.04e-05	0.000746	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—sarcoma	5.02e-05	0.000742	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—sarcoma	5e-05	0.000741	CcSEcCtD
Progesterone—Asthenia—Etoposide—sarcoma	4.99e-05	0.000739	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—sarcoma	4.99e-05	0.000739	CcSEcCtD
Progesterone—Angiopathy—Epirubicin—sarcoma	4.98e-05	0.000737	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—sarcoma	4.98e-05	0.000737	CcSEcCtD
Progesterone—Nausea—Mitoxantrone—sarcoma	4.97e-05	0.000735	CcSEcCtD
Progesterone—Immune system disorder—Epirubicin—sarcoma	4.96e-05	0.000734	CcSEcCtD
Progesterone—Mediastinal disorder—Epirubicin—sarcoma	4.95e-05	0.000732	CcSEcCtD
Progesterone—Pruritus—Etoposide—sarcoma	4.92e-05	0.000729	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—sarcoma	4.89e-05	0.000724	CcSEcCtD
Progesterone—Alopecia—Epirubicin—sarcoma	4.85e-05	0.000718	CcSEcCtD
Progesterone—Mental disorder—Epirubicin—sarcoma	4.81e-05	0.000712	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—sarcoma	4.8e-05	0.000711	CcSEcCtD
Progesterone—Malnutrition—Epirubicin—sarcoma	4.78e-05	0.000707	CcSEcCtD
Progesterone—Erythema—Epirubicin—sarcoma	4.78e-05	0.000707	CcSEcCtD
Progesterone—Diarrhoea—Etoposide—sarcoma	4.76e-05	0.000705	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—sarcoma	4.75e-05	0.000703	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—sarcoma	4.74e-05	0.000701	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—sarcoma	4.71e-05	0.000698	CcSEcCtD
Progesterone—Flatulence—Epirubicin—sarcoma	4.71e-05	0.000697	CcSEcCtD
Progesterone—Tension—Epirubicin—sarcoma	4.69e-05	0.000694	CcSEcCtD
Progesterone—Nervousness—Epirubicin—sarcoma	4.64e-05	0.000687	CcSEcCtD
Progesterone—Back pain—Epirubicin—sarcoma	4.62e-05	0.000684	CcSEcCtD
Progesterone—ABCB1—testis—sarcoma	4.62e-05	0.00145	CbGeAlD
Progesterone—Angiopathy—Doxorubicin—sarcoma	4.61e-05	0.000682	CcSEcCtD
Progesterone—Dizziness—Etoposide—sarcoma	4.6e-05	0.000681	CcSEcCtD
Progesterone—Muscle spasms—Epirubicin—sarcoma	4.59e-05	0.00068	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—sarcoma	4.59e-05	0.000679	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—sarcoma	4.58e-05	0.000678	CcSEcCtD
Progesterone—Vision blurred—Epirubicin—sarcoma	4.5e-05	0.000667	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—sarcoma	4.49e-05	0.000664	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—sarcoma	4.45e-05	0.000659	CcSEcCtD
Progesterone—Ill-defined disorder—Epirubicin—sarcoma	4.43e-05	0.000656	CcSEcCtD
Progesterone—Vomiting—Etoposide—sarcoma	4.42e-05	0.000655	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—sarcoma	4.42e-05	0.000654	CcSEcCtD
Progesterone—Erythema—Doxorubicin—sarcoma	4.42e-05	0.000654	CcSEcCtD
Progesterone—Anaemia—Epirubicin—sarcoma	4.42e-05	0.000654	CcSEcCtD
Progesterone—Rash—Etoposide—sarcoma	4.39e-05	0.000649	CcSEcCtD
Progesterone—Dermatitis—Etoposide—sarcoma	4.38e-05	0.000649	CcSEcCtD
Progesterone—ABCB1—liver—sarcoma	4.37e-05	0.00137	CbGeAlD
Progesterone—Headache—Etoposide—sarcoma	4.36e-05	0.000645	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—sarcoma	4.36e-05	0.000645	CcSEcCtD
Progesterone—Tension—Doxorubicin—sarcoma	4.34e-05	0.000642	CcSEcCtD
Progesterone—Malaise—Epirubicin—sarcoma	4.31e-05	0.000638	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—sarcoma	4.29e-05	0.000636	CcSEcCtD
Progesterone—Vertigo—Epirubicin—sarcoma	4.29e-05	0.000635	CcSEcCtD
Progesterone—Syncope—Epirubicin—sarcoma	4.28e-05	0.000634	CcSEcCtD
Progesterone—Back pain—Doxorubicin—sarcoma	4.28e-05	0.000633	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—sarcoma	4.25e-05	0.000629	CcSEcCtD
Progesterone—Palpitations—Epirubicin—sarcoma	4.22e-05	0.000625	CcSEcCtD
Progesterone—Loss of consciousness—Epirubicin—sarcoma	4.2e-05	0.000622	CcSEcCtD
Progesterone—Cough—Epirubicin—sarcoma	4.17e-05	0.000617	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—sarcoma	4.17e-05	0.000617	CcSEcCtD
Progesterone—Convulsion—Epirubicin—sarcoma	4.14e-05	0.000613	CcSEcCtD
Progesterone—Nausea—Etoposide—sarcoma	4.13e-05	0.000612	CcSEcCtD
Progesterone—Hypertension—Epirubicin—sarcoma	4.13e-05	0.000611	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—sarcoma	4.1e-05	0.000607	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—sarcoma	4.09e-05	0.000605	CcSEcCtD
Progesterone—Myalgia—Epirubicin—sarcoma	4.07e-05	0.000602	CcSEcCtD
Progesterone—Arthralgia—Epirubicin—sarcoma	4.07e-05	0.000602	CcSEcCtD
Progesterone—Chest pain—Epirubicin—sarcoma	4.07e-05	0.000602	CcSEcCtD
Progesterone—Anxiety—Epirubicin—sarcoma	4.05e-05	0.0006	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	4.04e-05	0.000598	CcSEcCtD
Progesterone—Discomfort—Epirubicin—sarcoma	4.02e-05	0.000595	CcSEcCtD
Progesterone—Malaise—Doxorubicin—sarcoma	3.99e-05	0.00059	CcSEcCtD
Progesterone—Dry mouth—Epirubicin—sarcoma	3.98e-05	0.000589	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—sarcoma	3.97e-05	0.000588	CcSEcCtD
Progesterone—Syncope—Doxorubicin—sarcoma	3.96e-05	0.000587	CcSEcCtD
Progesterone—Confusional state—Epirubicin—sarcoma	3.93e-05	0.000582	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—sarcoma	3.91e-05	0.000578	CcSEcCtD
Progesterone—Oedema—Epirubicin—sarcoma	3.9e-05	0.000577	CcSEcCtD
Progesterone—Anaphylactic shock—Epirubicin—sarcoma	3.9e-05	0.000577	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—sarcoma	3.89e-05	0.000575	CcSEcCtD
Progesterone—Infection—Epirubicin—sarcoma	3.87e-05	0.000573	CcSEcCtD
Progesterone—Cough—Doxorubicin—sarcoma	3.86e-05	0.000571	CcSEcCtD
Progesterone—Shock—Epirubicin—sarcoma	3.84e-05	0.000568	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—sarcoma	3.83e-05	0.000567	CcSEcCtD
Progesterone—Nervous system disorder—Epirubicin—sarcoma	3.82e-05	0.000566	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—sarcoma	3.82e-05	0.000565	CcSEcCtD
Progesterone—Tachycardia—Epirubicin—sarcoma	3.81e-05	0.000563	CcSEcCtD
Progesterone—Skin disorder—Epirubicin—sarcoma	3.79e-05	0.000561	CcSEcCtD
Progesterone—Hyperhidrosis—Epirubicin—sarcoma	3.77e-05	0.000558	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—sarcoma	3.76e-05	0.000557	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—sarcoma	3.76e-05	0.000557	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—sarcoma	3.76e-05	0.000557	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—sarcoma	3.75e-05	0.000555	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	3.74e-05	0.000553	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—sarcoma	3.72e-05	0.00055	CcSEcCtD
Progesterone—Anorexia—Epirubicin—sarcoma	3.72e-05	0.00055	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—sarcoma	3.68e-05	0.000545	CcSEcCtD
Progesterone—Hypotension—Epirubicin—sarcoma	3.64e-05	0.000539	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—sarcoma	3.64e-05	0.000539	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—sarcoma	3.61e-05	0.000534	CcSEcCtD
Progesterone—Oedema—Doxorubicin—sarcoma	3.61e-05	0.000534	CcSEcCtD
Progesterone—Infection—Doxorubicin—sarcoma	3.58e-05	0.000531	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Epirubicin—sarcoma	3.55e-05	0.000526	CcSEcCtD
Progesterone—Shock—Doxorubicin—sarcoma	3.55e-05	0.000525	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—sarcoma	3.54e-05	0.000524	CcSEcCtD
Progesterone—Insomnia—Epirubicin—sarcoma	3.53e-05	0.000522	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—sarcoma	3.52e-05	0.000521	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—sarcoma	3.5e-05	0.000519	CcSEcCtD
Progesterone—Paraesthesia—Epirubicin—sarcoma	3.5e-05	0.000518	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—sarcoma	3.49e-05	0.000516	CcSEcCtD
Progesterone—Dyspnoea—Epirubicin—sarcoma	3.48e-05	0.000515	CcSEcCtD
Progesterone—Somnolence—Epirubicin—sarcoma	3.47e-05	0.000513	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—sarcoma	3.44e-05	0.000509	CcSEcCtD
Progesterone—Dyspepsia—Epirubicin—sarcoma	3.43e-05	0.000508	CcSEcCtD
Progesterone—Decreased appetite—Epirubicin—sarcoma	3.39e-05	0.000502	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—sarcoma	3.37e-05	0.000499	CcSEcCtD
Progesterone—Gastrointestinal disorder—Epirubicin—sarcoma	3.37e-05	0.000498	CcSEcCtD
Progesterone—Fatigue—Epirubicin—sarcoma	3.36e-05	0.000498	CcSEcCtD
Progesterone—ABCB1—lymph node—sarcoma	3.35e-05	0.00105	CbGeAlD
Progesterone—Constipation—Epirubicin—sarcoma	3.33e-05	0.000494	CcSEcCtD
Progesterone—Pain—Epirubicin—sarcoma	3.33e-05	0.000494	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—sarcoma	3.29e-05	0.000487	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—sarcoma	3.26e-05	0.000483	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—sarcoma	3.24e-05	0.00048	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—sarcoma	3.22e-05	0.000476	CcSEcCtD
Progesterone—Feeling abnormal—Epirubicin—sarcoma	3.21e-05	0.000476	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—sarcoma	3.21e-05	0.000475	CcSEcCtD
Progesterone—Gastrointestinal pain—Epirubicin—sarcoma	3.19e-05	0.000472	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—sarcoma	3.18e-05	0.00047	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—sarcoma	3.14e-05	0.000464	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—sarcoma	3.12e-05	0.000461	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—sarcoma	3.11e-05	0.00046	CcSEcCtD
Progesterone—Urticaria—Epirubicin—sarcoma	3.1e-05	0.000459	CcSEcCtD
Progesterone—Pain—Doxorubicin—sarcoma	3.09e-05	0.000457	CcSEcCtD
Progesterone—Constipation—Doxorubicin—sarcoma	3.09e-05	0.000457	CcSEcCtD
Progesterone—Body temperature increased—Epirubicin—sarcoma	3.08e-05	0.000456	CcSEcCtD
Progesterone—Abdominal pain—Epirubicin—sarcoma	3.08e-05	0.000456	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—sarcoma	2.97e-05	0.00044	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—sarcoma	2.95e-05	0.000437	CcSEcCtD
Progesterone—Hypersensitivity—Epirubicin—sarcoma	2.87e-05	0.000425	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—sarcoma	2.87e-05	0.000424	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—sarcoma	2.85e-05	0.000422	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—sarcoma	2.85e-05	0.000422	CcSEcCtD
Progesterone—Asthenia—Epirubicin—sarcoma	2.8e-05	0.000414	CcSEcCtD
Progesterone—Pruritus—Epirubicin—sarcoma	2.76e-05	0.000408	CcSEcCtD
Progesterone—Diarrhoea—Epirubicin—sarcoma	2.67e-05	0.000395	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—sarcoma	2.66e-05	0.000394	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—sarcoma	2.59e-05	0.000383	CcSEcCtD
Progesterone—Dizziness—Epirubicin—sarcoma	2.58e-05	0.000382	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—sarcoma	2.55e-05	0.000378	CcSEcCtD
Progesterone—Vomiting—Epirubicin—sarcoma	2.48e-05	0.000367	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—sarcoma	2.47e-05	0.000365	CcSEcCtD
Progesterone—Rash—Epirubicin—sarcoma	2.46e-05	0.000364	CcSEcCtD
Progesterone—Dermatitis—Epirubicin—sarcoma	2.46e-05	0.000364	CcSEcCtD
Progesterone—Headache—Epirubicin—sarcoma	2.44e-05	0.000362	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—sarcoma	2.39e-05	0.000353	CcSEcCtD
Progesterone—Nausea—Epirubicin—sarcoma	2.32e-05	0.000343	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—sarcoma	2.29e-05	0.00034	CcSEcCtD
Progesterone—Rash—Doxorubicin—sarcoma	2.28e-05	0.000337	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—sarcoma	2.27e-05	0.000336	CcSEcCtD
Progesterone—Headache—Doxorubicin—sarcoma	2.26e-05	0.000335	CcSEcCtD
Progesterone—Nausea—Doxorubicin—sarcoma	2.14e-05	0.000317	CcSEcCtD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	1.7e-05	0.00104	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.7e-05	0.00104	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.69e-05	0.00103	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—CREB1—sarcoma	1.69e-05	0.00103	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—HRAS—sarcoma	1.69e-05	0.00103	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.68e-05	0.00103	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—sarcoma	1.67e-05	0.00102	CbGpPWpGaD
Progesterone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	1.65e-05	0.00101	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PLCG1—sarcoma	1.65e-05	0.00101	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—MYC—sarcoma	1.64e-05	0.001	CbGpPWpGaD
Progesterone—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	1.62e-05	0.000987	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—EGFR—sarcoma	1.61e-05	0.000982	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—CREB1—sarcoma	1.58e-05	0.000964	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—sarcoma	1.58e-05	0.000964	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—JUN—sarcoma	1.57e-05	0.000962	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	1.56e-05	0.000955	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	1.54e-05	0.000943	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	1.54e-05	0.000943	CbGpPWpGaD
Progesterone—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	1.53e-05	0.000934	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.52e-05	0.000928	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—KRAS—sarcoma	1.52e-05	0.000927	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—JUN—sarcoma	1.51e-05	0.000923	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	1.5e-05	0.000919	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.5e-05	0.000917	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	1.5e-05	0.000916	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	1.49e-05	0.000907	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.48e-05	0.000904	CbGpPWpGaD
Progesterone—NR3C2—Generic Transcription Pathway—MYC—sarcoma	1.46e-05	0.00089	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—IL2—sarcoma	1.44e-05	0.000878	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—ENO2—sarcoma	1.42e-05	0.00087	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—HBA1—sarcoma	1.42e-05	0.000865	CbGpPWpGaD
Progesterone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	1.41e-05	0.000862	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TLE1—sarcoma	1.41e-05	0.000861	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—MDM2—sarcoma	1.4e-05	0.000856	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	1.38e-05	0.000845	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	1.38e-05	0.00084	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.36e-05	0.000832	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	1.35e-05	0.000827	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	1.35e-05	0.000827	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—NRAS—sarcoma	1.35e-05	0.000826	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—TP53—sarcoma	1.35e-05	0.000824	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.33e-05	0.000813	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—sarcoma	1.32e-05	0.000806	CbGpPWpGaD
Progesterone—ABCC1—Disease—TLE1—sarcoma	1.31e-05	0.000802	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CXCR4—sarcoma	1.31e-05	0.0008	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.31e-05	0.000799	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—MDM2—sarcoma	1.31e-05	0.000798	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.31e-05	0.000797	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	1.3e-05	0.000794	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—CREB1—sarcoma	1.3e-05	0.000793	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.3e-05	0.000791	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	1.28e-05	0.000781	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—MYC—sarcoma	1.27e-05	0.000773	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.26e-05	0.000768	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—sarcoma	1.24e-05	0.000756	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—EGFR—sarcoma	1.23e-05	0.000752	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—VEGFA—sarcoma	1.22e-05	0.000747	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—CREB1—sarcoma	1.21e-05	0.000739	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PLCG1—sarcoma	1.21e-05	0.000738	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—ENO2—sarcoma	1.19e-05	0.000729	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CXCR4—sarcoma	1.19e-05	0.000727	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFC—sarcoma	1.19e-05	0.000726	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—HBA1—sarcoma	1.19e-05	0.000724	CbGpPWpGaD
Progesterone—ABCC1—Disease—NPM1—sarcoma	1.18e-05	0.000724	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.17e-05	0.000715	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—sarcoma	1.17e-05	0.000714	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—KRAS—sarcoma	1.16e-05	0.000711	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—ENO2—sarcoma	1.14e-05	0.000699	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.14e-05	0.000696	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—HBA1—sarcoma	1.14e-05	0.000694	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.12e-05	0.000683	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TLE1—sarcoma	1.1e-05	0.000674	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	1.09e-05	0.000664	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—MDM2—sarcoma	1.07e-05	0.000656	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.05e-05	0.000641	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—TP53—sarcoma	1.04e-05	0.000635	CbGpPWpGaD
Progesterone—ABCC1—Disease—ENO2—sarcoma	1.03e-05	0.000627	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.03e-05	0.000627	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PLCG1—sarcoma	1.01e-05	0.000618	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—MDM2—sarcoma	1e-05	0.000611	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—HRAS—sarcoma	9.89e-06	0.000604	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PLCG1—sarcoma	9.71e-06	0.000593	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	9.69e-06	0.000592	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	9.6e-06	0.000586	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—FLT1—sarcoma	9.5e-06	0.00058	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PLCG1—sarcoma	9.34e-06	0.000571	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFC—sarcoma	9.31e-06	0.000569	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CXCR4—sarcoma	8.98e-06	0.000548	CbGpPWpGaD
Progesterone—PGR—Generic Transcription Pathway—MYC—sarcoma	8.88e-06	0.000542	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—ATF1—sarcoma	8.87e-06	0.000542	CbGpPWpGaD
Progesterone—ABCC1—Disease—PLCG1—sarcoma	8.71e-06	0.000532	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	8.61e-06	0.000526	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ENO2—sarcoma	8.59e-06	0.000525	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—HBA1—sarcoma	8.54e-06	0.000522	CbGpPWpGaD
Progesterone—ABCC1—Disease—CXCR4—sarcoma	8.37e-06	0.000511	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ENO2—sarcoma	8.31e-06	0.000508	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TLE1—sarcoma	8.27e-06	0.000505	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—HBA1—sarcoma	8.26e-06	0.000504	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	7.94e-06	0.000485	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—HRAS—sarcoma	7.69e-06	0.00047	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ENO2—sarcoma	7.5e-06	0.000458	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ENO2—sarcoma	7.48e-06	0.000457	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—HBA1—sarcoma	7.45e-06	0.000455	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—FLT1—sarcoma	7.44e-06	0.000455	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—HBA1—sarcoma	7.44e-06	0.000454	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PLCG1—sarcoma	7.32e-06	0.000447	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PLCG1—sarcoma	7.29e-06	0.000445	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—HRAS—sarcoma	7.17e-06	0.000438	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PLCG1—sarcoma	7.05e-06	0.000431	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCR4—sarcoma	7.03e-06	0.000429	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—MYC—sarcoma	7.02e-06	0.000429	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFC—sarcoma	6.98e-06	0.000426	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ENO2—sarcoma	6.98e-06	0.000426	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IGF1R—sarcoma	6.96e-06	0.000425	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ATF1—sarcoma	6.95e-06	0.000425	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—HBA1—sarcoma	6.93e-06	0.000423	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	6.92e-06	0.000423	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	6.9e-06	0.000422	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ENO2—sarcoma	6.87e-06	0.00042	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	6.85e-06	0.000418	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—HBA1—sarcoma	6.83e-06	0.000417	CbGpPWpGaD
Progesterone—AR—Generic Transcription Pathway—MYC—sarcoma	6.76e-06	0.000413	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—FOXO1—sarcoma	6.63e-06	0.000405	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PDGFRB—sarcoma	6.62e-06	0.000404	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PDGFRA—sarcoma	6.51e-06	0.000398	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CREB1—sarcoma	6.37e-06	0.000389	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PLCG1—sarcoma	6.36e-06	0.000388	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PLCG1—sarcoma	6.35e-06	0.000388	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	6.19e-06	0.000378	CbGpPWpGaD
Progesterone—ABCC1—Disease—FOXO1—sarcoma	6.18e-06	0.000377	CbGpPWpGaD
Progesterone—ABCC1—Disease—PDGFRB—sarcoma	6.17e-06	0.000377	CbGpPWpGaD
Progesterone—ABCC1—Disease—PDGFRA—sarcoma	6.07e-06	0.000371	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	6.03e-06	0.000368	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PLCG1—sarcoma	5.92e-06	0.000361	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—HRAS—sarcoma	5.89e-06	0.00036	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PLCG1—sarcoma	5.83e-06	0.000356	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FLT1—sarcoma	5.58e-06	0.000341	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	5.55e-06	0.000339	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—HRAS—sarcoma	5.49e-06	0.000335	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KDR—sarcoma	5.48e-06	0.000335	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PLCG1—sarcoma	5.48e-06	0.000335	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IGF1R—sarcoma	5.45e-06	0.000333	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	5.43e-06	0.000332	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ENO2—sarcoma	5.42e-06	0.000331	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—HBA1—sarcoma	5.38e-06	0.000329	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCR4—sarcoma	5.27e-06	0.000322	CbGpPWpGaD
Progesterone—ESR1—Generic Transcription Pathway—MYC—sarcoma	5.21e-06	0.000318	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ATF1—sarcoma	5.21e-06	0.000318	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—FOXO1—sarcoma	5.19e-06	0.000317	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—IL2—sarcoma	5.19e-06	0.000317	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PDGFRB—sarcoma	5.18e-06	0.000317	CbGpPWpGaD
Progesterone—NR3C1—Generic Transcription Pathway—MYC—sarcoma	5.13e-06	0.000313	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	5.13e-06	0.000313	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ENO2—sarcoma	5.12e-06	0.000313	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PDGFRA—sarcoma	5.1e-06	0.000312	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—HBA1—sarcoma	5.09e-06	0.000311	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KIT—sarcoma	5.05e-06	0.000308	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CREB1—sarcoma	4.81e-06	0.000294	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL2—sarcoma	4.71e-06	0.000288	CbGpPWpGaD
Progesterone—ABCC1—Disease—KIT—sarcoma	4.71e-06	0.000288	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ENO2—sarcoma	4.69e-06	0.000287	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—HBA1—sarcoma	4.66e-06	0.000285	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PLCG1—sarcoma	4.6e-06	0.000281	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	4.56e-06	0.000278	CbGpPWpGaD
Progesterone—ABCC1—Disease—CREB1—sarcoma	4.48e-06	0.000274	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PLCG1—sarcoma	4.34e-06	0.000265	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KDR—sarcoma	4.29e-06	0.000262	CbGpPWpGaD
Progesterone—PGR—Gene Expression—MYC—sarcoma	4.27e-06	0.000261	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ENO2—sarcoma	4.19e-06	0.000256	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—HBA1—sarcoma	4.16e-06	0.000254	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ENO2—sarcoma	4.09e-06	0.00025	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IGF1R—sarcoma	4.09e-06	0.00025	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—HBA1—sarcoma	4.06e-06	0.000248	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PLCG1—sarcoma	3.98e-06	0.000243	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MDM2—sarcoma	3.98e-06	0.000243	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KIT—sarcoma	3.96e-06	0.000242	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—NRAS—sarcoma	3.96e-06	0.000242	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FOXO1—sarcoma	3.89e-06	0.000238	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PDGFRB—sarcoma	3.88e-06	0.000237	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ENO2—sarcoma	3.85e-06	0.000235	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—HBA1—sarcoma	3.83e-06	0.000234	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PDGFRA—sarcoma	3.82e-06	0.000233	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ENO2—sarcoma	3.82e-06	0.000233	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—HBA1—sarcoma	3.8e-06	0.000232	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CREB1—sarcoma	3.77e-06	0.00023	CbGpPWpGaD
Progesterone—ABCC1—Disease—MDM2—sarcoma	3.71e-06	0.000226	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—EGFR—sarcoma	3.6e-06	0.00022	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PLCG1—sarcoma	3.55e-06	0.000217	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL2—sarcoma	3.55e-06	0.000217	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PLCG1—sarcoma	3.47e-06	0.000212	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCND1—sarcoma	3.46e-06	0.000212	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—JUN—sarcoma	3.46e-06	0.000211	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CTNNB1—sarcoma	3.43e-06	0.00021	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—KRAS—sarcoma	3.4e-06	0.000208	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PLCG1—sarcoma	3.27e-06	0.0002	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ENO2—sarcoma	3.26e-06	0.000199	CbGpPWpGaD
Progesterone—AR—Gene Expression—MYC—sarcoma	3.26e-06	0.000199	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—HBA1—sarcoma	3.24e-06	0.000198	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PLCG1—sarcoma	3.24e-06	0.000198	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KDR—sarcoma	3.22e-06	0.000197	CbGpPWpGaD
Progesterone—ABCC1—Disease—CTNNB1—sarcoma	3.2e-06	0.000195	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MDM2—sarcoma	3.12e-06	0.00019	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SRC—sarcoma	3.1e-06	0.000189	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—sarcoma	3.02e-06	0.000184	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NRAS—sarcoma	2.98e-06	0.000182	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KIT—sarcoma	2.96e-06	0.000181	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HRAS—sarcoma	2.89e-06	0.000177	CbGpPWpGaD
Progesterone—ABCC1—Disease—SRC—sarcoma	2.89e-06	0.000177	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CREB1—sarcoma	2.82e-06	0.000172	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL2—sarcoma	2.78e-06	0.00017	CbGpPWpGaD
Progesterone—ABCC1—Disease—NRAS—sarcoma	2.78e-06	0.00017	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MYC—sarcoma	2.78e-06	0.00017	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PLCG1—sarcoma	2.77e-06	0.000169	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—sarcoma	2.72e-06	0.000166	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCND1—sarcoma	2.71e-06	0.000166	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—JUN—sarcoma	2.71e-06	0.000165	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CTNNB1—sarcoma	2.69e-06	0.000164	CbGpPWpGaD
Progesterone—ABCC1—Disease—MYC—sarcoma	2.59e-06	0.000158	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—sarcoma	2.57e-06	0.000157	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—sarcoma	2.53e-06	0.000155	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ENO2—sarcoma	2.52e-06	0.000154	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—sarcoma	2.51e-06	0.000153	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—HBA1—sarcoma	2.5e-06	0.000153	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—sarcoma	2.47e-06	0.000151	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SRC—sarcoma	2.43e-06	0.000148	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—sarcoma	2.39e-06	0.000146	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—sarcoma	2.37e-06	0.000144	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRAS—sarcoma	2.34e-06	0.000143	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MDM2—sarcoma	2.33e-06	0.000143	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—sarcoma	2.28e-06	0.000139	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—sarcoma	2.18e-06	0.000133	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—sarcoma	2.18e-06	0.000133	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PLCG1—sarcoma	2.14e-06	0.000131	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—sarcoma	2.13e-06	0.00013	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—sarcoma	2.09e-06	0.000127	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—sarcoma	2.03e-06	0.000124	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—sarcoma	2.03e-06	0.000124	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—JUN—sarcoma	2.03e-06	0.000124	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CTNNB1—sarcoma	2.01e-06	0.000123	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—sarcoma	2.01e-06	0.000123	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SRC—sarcoma	1.82e-06	0.000111	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—sarcoma	1.79e-06	0.000109	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—sarcoma	1.77e-06	0.000108	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRAS—sarcoma	1.75e-06	0.000107	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—sarcoma	1.71e-06	0.000104	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—sarcoma	1.63e-06	9.96e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—sarcoma	1.6e-06	9.74e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—sarcoma	1.51e-06	9.2e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—sarcoma	1.34e-06	8.18e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—sarcoma	1.28e-06	7.82e-05	CbGpPWpGaD
